Frequency and Prognostic Significance of Intertumoural Heterogeneity in Multifocal Jejunoileal Neuroendocrine Tumours

被引:4
作者
Jesinghaus, Moritz [1 ,2 ]
Poppinga, Jelte [3 ,4 ]
Lehman, Bettina [3 ,4 ]
Maurer, Elisabeth [3 ,4 ]
Ramaswamy, Annette [1 ,2 ]
Grass, Albert [1 ,2 ]
Di Fazio, Pietro [3 ,4 ]
Rinke, Anja [4 ,5 ]
Denkert, Carsten [1 ,2 ]
Bartsch, Detlef K. [3 ,4 ]
机构
[1] Phillips Univ Marburg, Inst Pathol, D-35043 Marburg, Germany
[2] Univ Hosp Marburg, Inst Pathol, D-35043 Marburg, Germany
[3] Phillips Univ Marburg, Dept Visceral Thorac & Vasc Surg, D-35043 Marburg, Germany
[4] Univ Hosp Marburg, D-35043 Marburg, Germany
[5] Phillips Univ Marburg, Dept Gastroenterol, D-35043 Marburg, Germany
关键词
multifocal neuroendocrine tumors; SI-NETs; intertumoral heterogeneity; ENETS CONSENSUS GUIDELINES; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; NEOPLASMS; JEJUNUM; MIDGUT; METASTASES; MANAGEMENT; HINDGUT; ILEUM; LIVER;
D O I
10.3390/cancers14163963
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Well differentiated jejunoileal neuroendocrine tumors (SI-NETs) commonly present as multiple primaries, which are believed to be clonally unrelated. Our study aimed to explore whether these multifocal lesions show intertumoral differences between the most common histomorphological parameters and if so, whether these differences can be associated with patient prognosis. While WHO grade and standard neuroendocrine markers were found to be mostly stable, we observed intertumoral heterogeneity in the expression of SSTR2, CDX2, and serotonin, but observed no survival differences between the expression groups or in comparison to unifocal NETs. Although multifocal SI-NETs showed some degree of heterogeneity in their central morphological parameters, these findings do not appear to be of major clinical significance, rendering an extensive testing of all multifocal lesions as not necessarily required. Background: A recent study found that multifocal jejunoileal neuroendocrine tumors (SI-NETs) are genetically unrelated synchronous neoplasms. So far, it is unclear if this finding of synchronous independent neoplasms is mirrored by heterogeneity of key morphological parameters of SI-NETs and how it affects patient survival. Methods: We separately assessed WHO grade (based on the Ki-67 index), expression of basal diagnostic markers (synaptophysin/chromogranin A/CDX2/serotonin), SSTR2a, and the contexture of the immunogenic microenvironment in 146 separate tumors from 28 patients with multifocal SI-NETs and correlated the results with clinicopathological factors and survival. Results: Synaptophysin and chromogranin A were strongly expressed in all tumors. WHO grade was concordant within all multifocal lesions in more than 80% of cases and the highest grade was usually found in the most advanced primary. Intertumoral expression of serotonin, SSTR2, and CDX2 was discrepant in 32%, 43%, and 50% of all patients, respectively. Neither heterogeneity of any of the aforementioned markers nor multifocality itself had any impact on patient survival (p = n.s.). Discussion: Multifocal SI-NET show considerable variability in some of the central diagnostic parameters. However, neither intertumoral heterogeneity of those parameters nor multifocality itself had any impact on patient survival, showing that extensive testing of all multifocal lesions is not necessarily required.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Clinical significance of neuroendocrine tumors Incidence, symptoms, diagnosis, stage, and prognostic factors and their influence on disease management
    Hartrampf, Philipp E.
    Serfling, Sebastian E.
    Higuchi, Takahiro
    Bojunga, Joerg
    Weich, Alexander
    Werner, Rudolf A.
    RADIOLOGIE, 2024, 64 (07): : 536 - 545
  • [32] Paraneoplastic syndromes in patients with laryngeal neuroendocrine carcinomas: clinical manifestations and prognostic significance
    Ferlito, Alfio
    Rinaldo, Alessandra
    Bishop, Justin A.
    Hunt, Jennifer L.
    Vander Poorten, Vincent
    Williams, Michelle D.
    Triantafyllou, Asterios
    Devaney, Kenneth O.
    Gnepp, Douglas R.
    Kusafuka, Kimihide
    Halmos, Gyorgy B.
    Westra, William H.
    Takes, Robert P.
    Thompson, Lester D. R.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2016, 273 (03) : 533 - 536
  • [33] Clinical features and prognostic factors of duodenal neuroendocrine tumours: A comparative study of ampullary and nonampullary regions
    Fang, Sa
    Shi, Yu-Peng
    Wang, Lu
    Han, Shuang
    Shi, Yong-Quan
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 16 (03) : 907 - 918
  • [34] Prognostic predictors for recurrence following curative resection in grade I/II pancreatic neuroendocrine tumours
    Chopde, Amit
    Gupta, Amit
    Chaudhari, Vikram
    Parghane, Rahul
    Basu, Sandip
    Ostwal, Vikas
    Ramaswamy, Anant
    Puranik, Ameya
    Shrikhande, Shailesh V.
    Bhandare, Manish S.
    LANGENBECKS ARCHIVES OF SURGERY, 2023, 408 (01)
  • [35] Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: A meta-analysis
    Cen, Dong
    Chen, Jiang
    Li, Zheyong
    Zhao, Jie
    Cai, Xiujun
    PLOS ONE, 2017, 12 (11):
  • [36] 18F-FDG PET/CT and nestin expression as prognostic tools in pulmonary neuroendocrine tumours
    Brominska, Barbara
    Czepczynski, Rafal
    Gabryel, Piotr
    Jarmolowska-Jurczyszyn, Donata
    Janicka-Jedynska, Malgorzata
    Sawicka-Gutaj, Nadia
    Gut, Pawel
    Brominski, Gabriel
    Dyszkiewicz, Wojciech
    Ruchala, Marek
    NUCLEAR MEDICINE COMMUNICATIONS, 2019, 40 (04) : 353 - 360
  • [37] Prognostic significance of specific magnetic resonance imaging features in canine nasal tumours treated by radiotherapy
    Agthe, P.
    Caine, A. R.
    Gear, R. N. A.
    Dobson, J. M.
    Richardson, K. J.
    Herrtage, M. E.
    JOURNAL OF SMALL ANIMAL PRACTICE, 2009, 50 (12) : 641 - 648
  • [38] Evaluation of Clinical Prognostic Factors and Further Delineation of the Effect of Mesenteric Fibrosis on Survival in Advanced Midgut Neuroendocrine Tumours
    Laskaratos, Faidon-Marios
    Walker, Martin
    Wilkins, Dominic
    Tuck, Alexander
    Ramakrishnan, Shashank
    Phillips, Edward
    Gertner, Julian
    Megapanou, Maria
    Papantoniou, Dimitrios
    Shah, Ruchir
    Banks, Jamie
    Vlachou, Erasmia
    Garcia-Hernandez, Jorge
    Woodbridge, Lorna
    Papadopoulou, Anthie
    Grant, Lee
    Theocharidou, Eleni
    Watkins, Jennifer
    Tu Vinh Luong
    Mandair, Dalvinder
    Caplin, Martyn
    Toumpanakis, Christos
    NEUROENDOCRINOLOGY, 2018, 107 (03) : 292 - 304
  • [39] Prognostic model of survival for typical bronchial carcinoid tumours: analysis of 1109 patients on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours Working Group
    Filosso, Pier Luigi
    Guerrera, Francesco
    Evangelista, Andrea
    Welter, Stefan
    Thomas, Pascal
    Casado, Paula Moreno
    Rendina, Erino Angelo
    Venuta, Federico
    Ampollini, Luca
    Brunelli, Alessandro
    Stella, Franco
    Nosotti, Mario
    Raveglia, Federico
    Larocca, Valentina
    Rena, Ottavio
    Margaritora, Stefano
    Ardissone, Francesco
    Travis, William D.
    Sarkaria, Inderpal
    Sagan, Dariusz
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2015, 48 (03) : 441 - 447
  • [40] Effect of Tumor Heterogeneity on the Assessment of Ki67 Labeling Index in Well-differentiated Neuroendocrine Tumors Metastatic to the Liver: Implications for Prognostic Stratification
    Yang, Zhaohai
    Tang, Laura H.
    Klimstra, David S.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (06) : 853 - 860